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ABSTRACT In Staphylococcus aureus, hundreds of small regulatory or small RNAs (sRNAs) have been identified, yet this class of
molecule remains poorly understood and severely understudied. sRNA genes are typically absent from genome annotation files,
and as a consequence, their existence is often overlooked, particularly in global transcriptomic studies. To facilitate improved
detection and analysis of sRNAs in S. aureus, we generated updated GenBank files for three commonly used S. aureus strains
(MRSA252, NCTC 8325, and USA300), in which we added annotations for>260 previously identified sRNAs. These files, the first
to include genome-wide annotation of sRNAs in S. aureus, were then used as a foundation to identify novel sRNAs in the
community-associated methicillin-resistant strain USA300. This analysis led to the discovery of 39 previously unidentified sR-
NAs. Investigating the genomic loci of the newly identified sRNAs revealed a surprising degree of inconsistency in genome anno-
tation in S. aureus, which may be hindering the analysis and functional exploration of these elements. Finally, using our newly
created annotation files as a reference, we perform a global analysis of sRNA gene expression in S. aureus and demonstrate that
the newly identified tsr25 is the most highly upregulated sRNA in human serum. This study provides an invaluable resource to
the S. aureus research community in the form of our newly generated annotation files, while at the same time presenting the first
examination of differential sRNA expression in pathophysiologically relevant conditions.
IMPORTANCE Despite a large number of studies identifying regulatory or small RNA (sRNA) genes in Staphylococcus aureus,
their annotation is notably lacking in available genome files. In addition to this, there has been a considerable lack of cross-
referencing in the wealth of studies identifying these elements, often leading to the same sRNA being identified multiple times
and bearing multiple names. In this work, we have consolidated and curated known sRNA genes from the literature andmapped
them to their position on the S. aureus genome, creating new genome annotation files. These files can now be used by the scien-
tific community at large in experiments to search for previously undiscovered sRNA genes and to monitor sRNA gene expression
by transcriptome sequencing (RNA-seq). We demonstrate this application, identifying 39 new sRNAs and studying their expres-
sion during S. aureus growth in human serum.
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In recent years, a number of studies have been carried out, em-ploying both experimental and computational methods to iden-
tify regulatory or small RNAs (sRNAs) in Staphylococcus aureus
(1–12). Hundreds of sRNAs have been identified, and many, in
addition to the agr effector RNAIII, have been shown to play a role
in gene regulation (while these molecules go by a variety of names
such as regulatory RNAs or noncoding RNAs, we will use sRNAs
to refer to them all, as previously recommended [13]). Despite
advancements in sRNA identification, the roles of most of these
molecules remain unknown, because in many cases, limited func-
tional information can be gathered from analysis of their sequence
alone.
One additional factor that has hampered the study of sRNAs in
S. aureus has been the lack of a clear nomenclature and annotation
system. This absence of a systematic identification and annotation
process has led to the repeated discovery of the same sRNAs on
multiple occasions, the reidentification of already known sRNAs
(e.g., RNAIII), and even to important protein-coding genes being
ascribed as sRNAs (e.g., the -PSM transcript, which is not anno-
tated in most S. aureus genome files). Recent work by Sassi et al.
(14) established an online database for staphylococcal sRNAs;
however, most sRNAs, including the well-studied RNAIII, are still
not included in annotated S. aureus GenBank genome files. This is
a marked oversight, as annotated genome files serve as the refer-
ence for global genomic and transcriptomic studies; thus, the ab-
sence of sRNAs from these files severely impedes their study and
prevents us from gaining an overarching picture of regulatory
circuits.
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In S. aureus, most sRNA identification studies have been per-
formed in a single background, the hospital-acquired methicillin-
resistant S. aureus (MRSA) strain N315. The existence of many of
these sRNAs has been demonstrated experimentally in strain
N315 (1, 3, 4, 6, 7); however, very few of them have been investi-
gated in other S. aureus strains, including the epidemic
community-associated MRSA (CA-MRSA) strain USA300 (15).
As such, their existence, location, and copy number in most S. au-
reus isolates is unknown, preventing us from gaining a sense of
their role in the physiological and pathogenic differences between
strains.
To better understand the sRNA content of multiple S. aureus
strains, we explored the genomes of three well-studied S. aureus
strains (USA300, MRSA252, and NCTC 8325). We identified the
location(s) of previously discovered sRNAs and created new
GenBank genome annotation files for each strain, inserting ~260
sRNAs. These newly annotated files serve as a valuable resource
allowing us to do the following: (i) search the genome of each
strain for as yet unidentified sRNAs without mistakenly reidenti-
fying known species, and (ii) calculate expression values for these
genes using transcriptome sequencing (RNA-seq) data.
To demonstrate the application of these new files, we per-
formed RNA-seq on CA-MRSA strain USA300 growing in labo-
ratory media and human serum and aligned the data to our newly
created sRNA annotated genome files. Examining the data, we
identified 39 novel putative sRNAs that had not been previously
reported. These novel sRNAs were annotated, cross-referenced in
the genomes of strains NCTC 8325 and MRSA252, and added to
the newly created genome files as well. During the cross-
referencing process, we observed numerous examples of inconsis-
tent genome annotation in different S. aureus strains. We high-
light examples clearly demonstrating genome misannotation and
demonstrate how this phenomenon is adversely affecting the
identification and characterization of sRNAs. Finally, we calculate
expression values and examine the global sRNA expression profile
of strain USA300, uncovering a wealth of molecules that display
differential expression in human serum. The latter point is of sig-
nificant importance, as it gives us a unique look into the sRNA
transcriptome, not only during growth of S. aureus but also in a
pathophysiologically relevant growth environment. The new ge-
nome annotation files described in this work have been deposited
in the figshare depository and are freely available for download.
We suggest that these newly reannotated genomes will be a valu-
able resource to the S. aureus research community for sRNA iden-
tification and analysis hereafter, as they can be incrementally
added to as new sRNAs are discovered.
RESULTS
Annotation of sRNAs on the S. aureus genome. Previous studies
in our lab have utilized RNA-seq to determine the global tran-
scriptomic profile of S. aureus in the community-associated
MRSA strain USA300 (16, 17). Analysis of these data sets revealed
a large number of S. aureus transcripts that map to intergenic
regions where no protein-coding genes have been annotated. We
hypothesized that many of these transcripts represent sRNAs be-
cause of the following. (i) Most S. aureus genome annotation files
do not contain annotations for sRNA genes. (ii) Recent studies
carried out in the S. aureus N315 background have demonstrated
that there are several hundred sRNAs encoded in the S. aureus
genome (12, 14). To facilitate improved global transcriptomic
analysis of S. aureus by RNA-seq, we created new GenBank ge-
nome annotation files for three commonly used S. aureus strains,
NCTC 8325, MRSA252, and USA300. To do this, we elected to
expand the sRNA annotation and nomenclature system already
present for 25 sRNAs in strain MRSA252 (see Table S1 in the
supplemental material) and apply a similar annotation/nomen-
clature system to strains USA300 and NCTC 8325 (for details, see
supplemental material). To include annotations for known
sRNAs, we performed a literature search to identify studies in
which sRNAs in S. aureus were reported. A total of 12 papers that
employed a variety of methods to identify sRNAs, including com-
putational approaches, microarray studies, cDNA cloning, and
high-throughput sequencing, were investigated (1–12). Using the
information provided in these publications, a list of 928 potential
sRNAs was assembled (Table S2) (1–12). In order to ensure accu-
rate annotation of each sRNA from this list, RNA-seq experiments
were performed for each of the three strains growing under stan-
dard laboratory conditions. Reads generated from these works
were aligned to the respective genomes and used as a guide to
identify the specific location of each sRNA for each of the three
strains (see Fig. S1 in the supplemental material).
This work condensed the 928 putative sRNAs to a total of 248
annotations for strain MRSA252, 254 annotations for strain
NCTC 8325, and 264 annotations for strain USA300 (for a more-
comprehensive explanation of how sRNAs were identified and
annotated, see Text S1 in the supplemental material). Such a dra-
matic reduction in the number of sRNAs points to the scale of
overlapping identification, reidentification, and duplicate naming
that was extant in the literature for these elements and the poor
state of sRNA curation in S. aureus genomes. Our newly generated
GenBank files for all three strains represent the first comprehen-
sive list of sRNAs annotated directly in the S. aureus genome,
which will serve as a valuable reference point for future sRNA
discovery, and more broadly, global transcriptomic analyses of
S. aureus by RNA-seq.
Detection of novel sRNAs in strain USA300. The creation of
GenBank files containing annotations for previously identified
sRNAs provided us with a unique opportunity to examine RNA-
seq data for novel forms of these elements, without mistakenly
reidentifying those that are already known. Accordingly, we set
out to perform such an exploration using the community-
associated MRSA isolate USA300, an undeniably relevant clinical
strain for which no sRNA identification studies have yet been per-
formed. To maximize the probability of identifying novel sRNAs,
we performed RNA-seq with USA300 grown under both labora-
tory conditions (tryptic soy broth [TSB]), and in media that was
more pathophysiologically relevant to its infectious lifestyle (hu-
man serum) (18).
RNA-seq reads from bacteria grown under these conditions
were mapped to the newly created USA300 GenBank file (contain-
ing 264 sRNA annotations), followed by a thorough examination
for the presence of novel sRNA transcripts. A total of 39 potential
sRNAs were identified from both conditions, which we named tsr1
to tsr39 for Tampa small RNA (Table 1) (for details regarding the
criteria used for our determination of novel sRNAs, see Text S1 in
the supplemental material). Although the majority of the tsr genes
were located in intergenic regions, a number were identified as
being antisense to annotated genes or as partially overlapping an-
notated coding DNA sequence (CDS) genes. The novel sRNAs
were also added to our newly created USA300 genome file, using
Carroll et al.
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the nomenclature system described in Text S1, resulting in a Gen-
Bank file with a total of 303 sRNAs in the USA300 genome. This
brings the total number of genes annotated on the USA300 ge-
nome from 2,850 to 3,153, representing an approximately 10%
increase in annotated genes.
To investigate the conservation of tsr genes in S. aureus, we
analyzed their corresponding chromosomal loci on the S. aureus
NCTC 8325 and MRSA252 genomes by performing a BLAST
search (Table 1). Of the 39 tsr genes, 29 were found in strain
MRSA252, while 32 were found in strain NCTC 8325. Annota-
tions were again added to the MRSA252 and NCTC 8325 genome
files for each of the tsr genes identified using the nomenclature
outlined (see Text S1 in the supplemental material). Importantly,
five of the tsr genes appear to be unique to USA300 (tsr1, tsr2, tsr3,
tsr5, and tsr30), with no homologues found in either MRSA252 or
NCTC 8325. In addition, five tsr genes were present in USA300
and NCTC 8325 but absent in MRSA252 (tsr7, tsr8, tsr20, tsr24,
and tsr29), while two were present in USA300 and MRSA252 but
absent in NCTC 8325 (tsr26 and tsr27) (see Fig. S2 in the supple-
mental material).
Northern blot analysis of tsr transcripts. To validate our
RNA-seq-based approach for sRNA discovery, five putative tsr
transcripts were examined by Northern blot analysis. The tran-
scripts investigated had different expression patterns in TSB com-
pared to human serum. Three of the transcripts investigated (tsr8,
tsr26, and tsr31) showed no alteration in expression between TSB
and human serum, one (tsr25) demonstrated an increase in ex-
pression, while another (tsr33) showed a decrease (see Table S3 in
the supplemental material). Northern blot analysis confirmed the
predicted size and orientation of tsr25, tsr26, and tsr31 (Fig. 1). In
the case of tsr8 and tsr33, bands were identified; however, they
were considerably larger than those predicted by RNA-seq analy-
sis (Fig. 1). For example, the predicted size of tsr33 was 85 nucle-
otides (nt); however, the size observed by Northern blotting was
TABLE 1 Novel sRNAs identified in strain USA300
sRNA designation sRNA gene Stranda Location Size (nt)
Chromosomal location of tsr gene in strain:
USA300b MRSA252b NCTC 8325b
SAUSA300s265 tsr1  5243853094 656 IG  
SAUSA300s266 tsr2  5771257804 92 IG  
SAUSA300s267 tsr3  6138861550 162 IG  
SAUSA300s268 tsr4  7351174139 628 AS AS AS
SAUSA300s269 tsr5  7934679425 79 AS  
SAUSA300s270 tsr6  120785120897 112 IG IG IG
SAUSA300s271 tsr7  169903170079 176 IG  IG
SAUSA300s272 tsr8  170013170214 201 IG  IG
SAUSA300s273 tsr9  228412228796 384 IG CDS CDS
SAUSA300s274 tsr10  349895350058 163 IG OL OL
SAUSA300s275 tsr11  356689356782 93 OL OL OL
SAUSA300s276 tsr12  457272457333 61 IG OL AS
SAUSA300s277 tsr13  484942485025 83 OL OL OL
SAUSA300s278 tsr14  834340834885 545 IG IG AS
SAUSA300s279 tsr15  896563897379 816 AS AS AS
SAUSA300s280 tsr16  911246911364 118 AS OL OL
SAUSA300s281 tsr17  973559973971 412 IG CDS CDS
SAUSA300s282 tsr18  10742921074484 192 IG CDS CDS
SAUSA300s283 tsr19  10803021080394 92 IG IG IG
SAUSA300s284 tsr20  11543001154753 453 IG  IG
SAUSA300s285 tsr21  11548271156001 1174 CDS CDS3 CDS3
SAUSA300s286 tsr22  11654841165865 381 IG CDS CDS
SAUSA300s287 tsr23  12565211256545 24 IG IG IG
SAUSA300s288 tsr24  14295171429754 237 IG  IG
SAUSA300s289 tsr25  14428621443042 180 IG AS AS
SAUSA300s290 tsr26  16416111641732 121 IG IG 
SAUSA300s291 tsr27  16428201642923 103 IG IG 
SAUSA300s292 tsr28  17159001715975 75 OL OL OL
SAUSA300s293 tsr29  19549611955091 130 IG  IG
SAUSA300s294 tsr30  21264342126545 111 IG  
SAUSA300s295 tsr31  22449642245035 71 IG IG IG
SAUSA300s296 tsr32  23379222338072 150 IG IG CDS
SAUSA300s297 tsr33  24105642410648 84 IG IG IG
SAUSA300s298 tsr34  25910322591131 99 IG IG IG
SAUSA300s299 tsr35  26080472608594 547 IG CDS CDS
SAUSA300s300 tsr36  26081202608645 525 IG AS AS
SAUSA300s301 tsr37  26202852620621 336 IG CDS CDS
SAUSA300s302 tsr38  26648562664945 89 IG IG IG
SAUSA300s303 tsr39  28112782811330 52 IG IG IG
a, forward strand;, reverse strand.
b Characteristics of the chromosomal location of the tsr gene. IG, located in the intergenic region;, absent, deleted, or no homologue; AS, antisense to the annotated gene; CDS,
located within an existing annotated CDS; OL, partially overlaps CDS gene; CDS3, the corresponding locus contains three annotated CDSs.
sRNA Identiﬁcation and Annotation in S. aureus
January/February 2016 Volume 7 Issue 1 e01990-15 ® mbio.asm.org 3
 o
n
 August 17, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
approximately 600 nt. When looking at the tsr33 transcript, one
observes that it is located at the 3= end of the sarR gene and is
transcribed in the same orientation. The combined size of sarR
and tsr33 would be around 600 nt, therefore suggesting that tsr33
represents a large 3= untranslated region (UTR) for the sarR gene.
However, RNA-seq alignment from strain USA300 growing in
human serum demonstrates a much greater depth of coverage
(and hence abundance) of tsr33 than of sarR, suggesting that a
tsr33-specific RNA may exist under these conditions (see Fig. S3 in
the supplemental material). On the basis of the above informa-
tion, we predict that tsr33 is cotranscribed as a 3= UTR of sarR, but
under certain conditions (e.g., growth in human serum), it is pos-
sible that a tsr33 RNA may exist independently of sarR.
The second tsr demonstrating a size difference was tsr8, which
was predicted by RNA-seq to be 201 nt; however, two bands were
observed by Northern blotting with approximate sizes between
300 and 400 nucleotides. A possible explanation for this may come
from the fact that tsr8 and tsr7 are convergently transcribed, that
the two transcripts are complementary at the 3= ends, and that
these regions overlap. The density of reads, in both directions,
mapping to this region of complementarity make it difficult to
predict the precise location of each transcript based on RNA-seq
data, resulting in an underestimation of tsr8 size. Given our exper-
imental findings, the size of tsr8 was amended to ~350 nt in the
GenBank files. It is interesting to note that this type of genetic
organization (convergent transcripts overlapping at the 3= end) is
common among toxin-antitoxin (TA) systems in S. aureus (19,
20), hence tsr7 and tsr8 could potentially represent a novel serum-
induced TA system.
For some of the tsr elements expressed at low levels, Northern
blot detection proved unsuccessful (data not shown); therefore,
we employed a reverse transcriptase PCR (RT-PCR)-based ap-
proach, which is inherently more sensitive. Using this methodol-
ogy, we were able to validate the presence of an additional six
transcripts, tsr1, tsr2, tsr18, tsr24, tsr29, and tsr32 (see Fig. S4 in the
supplemental material), suggesting that our RNA-seq-based iden-
tification approach is effective at identifying legitimate sRNA mol-
ecules.
Inconsistent genome annotation in strains USA300, MRSA252,
and NCTC 8325. Twenty-seven tsr genes were found in the ge-
nomes of all three strains (USA300, MRSA252, and NCTC 8325).
For 14 of these genes, the corresponding genomic loci were simi-
larly annotated in all three strains, e.g., tsr6 is located in an inter-
genic region in all three strains, while tsr15 is located antisense to
an annotated CDS. Interestingly, for 13 tsr genes, the genomic loci
in the three strains studied are differentially annotated (Table 1).
In many cases, the NCTC 8325 and MRSA252 genomes contain
annotations for CDS genes, while the USA300 genome specifies
these loci as being intergenic (e.g., tsr9, tsr17, tsr18, etc.). An open
reading frame (ORF) search reveals that 11 tsr genes have the
potential to encode proteins (of 30 amino acids or larger in size).
Seven of these genes are annotated as CDS in strains MRSA252
and NCTC 8325. This raises the possibility that some tsr genes may
in fact be protein-coding genes that were omitted from the
USA300 genome annotation. Conversely, it is also possible that
the NCTC 8325 and MRSA252 genomes may be incorrect and that
these annotated genes do not encode proteins. Upon close exam-
ination, our data clearly demonstrate that incorrect genome an-
notation accounts for at least some of the discrepancies observed.
For example, the tsr12 locus is annotated differently in all three
FIG 1 Northern blot analysis of tsr transcripts. Northern blotting was performed using oligonucleotide probes specific for the tsr transcripts (tsr8, tsr25, tsr26,
tsr31, and tsr33). RNA-seq read alignments for each corresponding chromosomal location are shown, as are CDS genes (black arrows), and sRNAs (red arrows).
The depth of read coverage on the genome is shown by the blue histograms.
Carroll et al.
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strains (Fig. 2). In strain USA300, tsr12 is located in an intergenic
region (between SAUSA300_0404 and hsdM). In strain
MRSA252, tsr12 incompletely overlaps with a CDS gene anno-
tated in the same orientation, while in strain NCTC 8325, it par-
tially overlaps with a CDS gene annotated in the opposite direc-
tion. Bioinformatic analysis of these CDS genes reveals that they
both specify very small proteins (43 amino acids in MRSA252 and
33 amino acids in NCTC 8325) that possess no known structural
motifs and have no homology to any protein in the database be-
yond counterparts in a handful of other S. aureus strains. Further-
more, in USA300 and NCTC 8325, the tsr12 locus is 100% iden-
tical at the nucleotide level, making large-scale differences in
coding sequences (e.g., inverse open reading frames) unlikely.
Collectively, this demonstrates that there is likely misannotation
in the genomes of MRSA252 and NCTC 8325 and that our sug-
gested annotation of tsr12 as an sRNA is likely the correct one.
tsr12 is an example where incorrect genome annotation is
rather clear and raises important questions regarding how com-
monplace this type of genome misannotation may be. To investi-
gate the issue of inconsistent genome annotation in S. aureus fur-
ther, we selected another sRNA gene for additional study. Teg23
(SAUSA300s148, SARs145, SAOUHSCs144) was originally iden-
tified by Beaume et al. (7) as a potential 5= UTR of the SAS083 gene
in S. aureus strain N315. In strains NCTC 8325 and MRSA252, a
gene is annotated in the position corresponding to SAS083
(SAOUHSC_02572 and SAR2384, respectively), but no gene is
annotated in strain USA300 (Fig. 3A). Upon analysis, SAS083,
SAOUHSC_02572, and SAR2384 once again encode small, hypo-
thetical proteins with no known structural features, functional
domains, or apparent homologues and are therefore likely misan-
notated genes (as noted above for the tsr12 locus).
Northern blot analysis using S. aureus USA300 grown in hu-
man serum (where Teg23 is strongly upregulated) detected a band
of around 310 nt (as predicted by RNA-seq), alongside an addi-
tional band of approximately 215 nt (Fig. 3B). The smaller band
(which we designated Teg23.1) was more abundant than the larger
band (designated Teg23.2) and was repeatedly detected in multi-
ple Northern blots (data not shown), suggesting that two forms of
the transcript may exist within the cell. The CDS annotated in the
NCTC 8325 genome at the Teg23 position (SAOUHSC_02572)
potentially encodes a protein of 80 amino acids (Fig. 3C, red),
while the corresponding locus in strain MRSA252 (SAR2384) po-
tentially encodes a protein of 64 amino acids (Fig. 3C, blue). The
difference is due to a 4-bp insertion in the MRSA252 genome that
results in the creation of a stop codon (Fig. 3C). The nucleotide
sequence of the 432-bp intergenic region from strain USA300 is
almost identical with the corresponding locus in strain NCTC
8325 (431/432 identical), and it does not contain the 4-bp inser-
tion found in MRSA252 (Fig. 3C). Therefore, an 80-amino-acid
protein could potentially be generated from a transcript originat-
ing from this locus in USA300 (Fig. 3C, green), similar to NCTC
8325 (for simplicity, this potential protein will be referred to as
Teg23P for Teg23 protein).
To test whether Teg23P is produced in strain USA300, we
cloned a His6-tagged variant of its putative coding sequence, along
with its native promoter, into an S. aureus shuttle vector. Western
FIG 2 Variation in genome annotation of the tsr12 locus. RNA-seq read alignment data are shown for strains USA300 (A), MRSA252 (B), and NCTC 8325 (C).
Annotations for CDS genes are shown by black arrows, and the depth of coverage is shown by the blue histograms. The location of tsr12 is shown by a red arrow.
(A) There is no CDS annotation at the tsr12 locus in strain USA300. (B) In strain MRSA252, a gene (SAR0432) is annotated in the forward direction at the tsr12
locus. (C) In strain NCTC 8325, a gene (SAOUHSC_00396) is annotated in the reverse direction at the tsr12 locus.
sRNA Identiﬁcation and Annotation in S. aureus
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blots of USA300 strain bearing this construct revealed no detect-
able band using an antihistidine antibody, while the positive con-
trol (histidine-tagged RpoE) was detected (Fig. 3D). Quantitative
RT-PCR (qRT-PCR) to confirm that the construct was being ex-
pressed demonstrated a 2.92-fold-higher expression of Teg23 in
S. aureus containing the Teg23P-his6 plasmid (Fig. 3E). These data
confirm that the plasmid gene-encoded Teg23 is expressed; how-
ever, no protein corresponding to Teg23P-his6 is generated. This
strongly suggests that no protein corresponding to Teg23P is pro-
duced in strain USA300.
FIG 3 Analysis of the Teg23 locus. (A) Teg23 locus in S. aureus strains N315, USA300, NCTC 8325, and MRSA252. Annotated CDS genes are shown in gray.
The previously reported location of Teg23 is shown in white. (B) Northern blot analysis of Teg23. The Teg23 transcript was detected by Northern blot analysis
with a strand-specific oligonucleotide probe. Two bands were detected and were designated Teg23.1 (approximately 215 nt) and Teg23.2 (approximately 310 nt).
(C) Alignment of Teg23 DNA sequence in strains USA300, NCTC 8325, and MRSA252. Sequence corresponding to the SAOUHSC_02572 and SAR2384 CDS
genes is highlighted in red and blue, respectively. Sequence potentially encoding an 80-amino-acid protein (Teg23P) in strain USA300 is highlighted in green. (D)
Western blot to detect histidine-tagged Teg23P. No Teg23P protein was detected in S. aureus expressing the Teg23P-his plasmid (lane 1) or in a wild-type
S. aureus strain without the plasmid (lane 2). Histidine-tagged RpoE was detected as a positive control (lane 3). (E) Quantitative RT-PCR analysis of Teg23
expression. Expression of Teg23 was analyzed in the wild-type S. aureus strain with or without the Teg23P-his plasmid. Approximately 3-fold-higher expression
of Teg23 was detected in the strain expressing the Teg23P-his plasmid. Statistical significance was determined using Student’s t-test. *,P 0.05. (F) RNA-seq read
alignment at the Teg23 locus in strain NCTC 8325. RNA-seq reads aligned to the NCTC 8325 genome are shown in blue. The locations of annotated genes are
shown in gray. The locations of primers used for RT-PCR are shown in red. The predicted size and location of the Teg23.1 and Teg23.2 transcripts are shown by
red arrows. (G) RT-PCR analysis of Teg23 transcript. PCR was performed using the primer pairs indicated and S. aureus genomic DNA (gDNA) (lane 1), cDNA
from S. aureus containing the Teg23P-his plasmid (lane 2), cDNA from wild-type S. aureus (lane 3), or no DNA (lane 4). No PCR product was detected using
primers 1 and 3 with S. aureus cDNA as the template.
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The RNA-seq read alignment data demonstrate that99% of
the Teg23 reads in strain NCTC 8325 terminate 88 nucleotides
upstream of the annotated 3= end of the gene (Fig. 3F). Conse-
quently, transcript generated at this locus terminates before the
end of the annotated gene, and therefore, an 80-amino-acid pro-
tein corresponding to the SAOUHSC_02572 gene is unlikely to be
made. A similar pattern of transcript termination is observed in
the S. aureusUSA300 RNA-seq data set, further suggesting that the
Teg23P protein could not be produced in this strain (data not
shown). To test this further, we performed PCR using cDNA gen-
erated from total RNA from strain USA300. PCR performed using
primers that bind within the Teg23 sequence (primers 2 and 3
[Fig. 4F]) generated products using template cDNA from USA300
and USA300 containing the Teg23P-his6 plasmid (Fig. 3G). In
contrast, no product was generated in PCRs using one primer
within the Teg23 sequence and a second primer located at the 3=
end of the Teg23P sequence (primers 1 and 3 [Fig. 3F]). These data
show that the Teg23 RNA is being generated but that it terminates
prior to the 3= end of Teg23P, confirming the results from the
Western blot analysis that Teg23 does not encode an 80-amino-
acid protein.
While it is impossible to completely rule out the existence of a
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protein corresponding to Teg23P, these results strongly suggest
that the CDS annotations for Teg23P in strains N315, MRSA252,
and NCTC 8325 (i.e., SAS083, SAR2384, and SAOUHSC_02572,
respectively) are incorrect. Teg23 was originally identified as a 5=
UTR for the SAS083 gene (i.e., the gene encoding Teg23P in N315)
(7); however, the data presented herein demonstrates that this is
incorrect and Teg23 likely represents a nontranslated sRNA. This
comprehensively highlights how overannotation of genomes with
CDS genes may be masking the identification of transcripts that
encode sRNAs.
Global analysis of sRNA gene expression in strain USA300.
The inclusion of 303 sRNA gene annotations in the GenBank file
of strain USA300 allowed us to calculate global gene expression
values for sRNAs using our RNA-seq data sets. To examine vari-
ation in sRNA gene expression, we calculated and compared ex-
pression values for S. aureus USA300 growing in TSB and human
serum, two conditions known to result in widespread changes in
gene expression (18). The location, relative expression, and fold
change for each of the 303 sRNA genes in strain USA300 are
shown in Fig. 4 and Table S3 in the supplemental material. To
identify sRNA genes with meaningful differences in expression,
we applied cutoffs to eliminate genes expressed at low levels and
those displaying fold changes that are less than 3-fold (see
Text S1 in the supplemental material for details). This resulted in
a total of 83 sRNAs displaying alterations in gene expression under
the two conditions tested. Forty-two were upregulated in human
serum (Table 2), while 41 were downregulated (Table 3). Of the
newly identified tsr genes, 19 displayed differential regulation,
with 16 downregulated in serum, while 3 (tsr18, tsr25, and tsr30)
were upregulated. Interestingly, the newly identified tsr25 sRNA
demonstrated the largest upregulation in serum of any sRNA
(583-fold). To validate these findings, we performed Northern
TABLE 2 42 sRNAs that are upregulated in human serum versus TSB
sRNA designation
sRNA gene name
or feature
TSB expression
value (RPKM)b
Serum expression
value (RPKM) Fold change
SAUSA300s289 tsr25 60.67 35,374.06 583.02
SAUSA300s046 rsaOG 90.99 34,267.77 376.61
SAUSA300s053 RsaG 80.85 3,463.09 42.83
SAUSA300s119 ssr24 130.78 3,217.86 24.6
SAUSA300s153 Teg16 71.05 1,174.01 16.52
SAUSA300s066 Sau-63 104.99 1,690.95 16.11
SAUSA300s030 sprC 149.58 2,144.32 14.34
SAUSA300s026 ssrS 2,991.16 37,212.81 12.44
SAUSA300s005 ffs 929.74 11,188.00 12.03
SAUSA300s148 Teg23 256.6 2,950.59 11.5
SAUSA300s050 RsaD 2,737.91 30,473.59 11.13
SAUSA300s226 JKD6008sRNA173 50.05 539.79 10.78
SAUSA300s013 Lysine riboswitch 659.93 6,917.84 10.48
SAUSA300s260 JKD6008sRNA396 16.13 150.26 9.31
SAUSA300s294 tsr30 470.64 4,383.00 9.31
SAUSA300s027 sprA1 1,097.34 9,306.35 8.48
SAUSA300s233 JKD6008sRNA205 96.96 717.53 7.4
SAUSA300s003 T-box riboswitch 158.5 1,156.13 7.29
SAUSA300s094 Teg108 19.39 132.54 6.83
SAUSA300s099 Teg124 37.1 245.19 6.61
SAUSA300s110 sprA3 36.05 233.31 6.47
SAUSA300s282 tsr18 105.4 653.5 6.2
SAUSA300s024 GlmS ribozyme 185.53 1,064.95 5.74
SAUSA300s117 ssr8 12.13 67.9 5.6
SAUSA300s038 sprG3 191.04 1,049.33 5.49
SAUSA300s120 ssr28 188.03 1,012.53 5.39
SAUSA300s028 sprA2 99.08 504.62 5.09
SAUSA300s210 JKD6008sRNA071 136.39 691.13 5.07
SAUSA300s100 Teg124 469.39 2,313.98 4.93
SAUSA300s002 SAMa riboswitch 56.06 268.4 4.79
SAUSA300s031 sprD 804.11 3,810.91 4.74
SAUSA300s021 SAM riboswitch 239.09 941.21 3.94
SAUSA300s075 rsaOL 273.5 1,010.42 3.69
SAUSA300s091 Teg60 95.9 350.09 3.65
SAUSA300s034 sprF3 1,227.97 4,261.30 3.47
SAUSA300s016 T-box riboswitch 316.76 1,059.28 3.34
SAUSA300s084 Teg27 15,788.22 52,571.03 3.33
SAUSA300s042 rsaOC 26.75 88.89 3.32
SAUSA300s135 ssr100 322.65 1,050.22 3.26
SAUSA300s163 Teg28as 46.74 149.53 3.2
SAUSA300s079 rsaOU 0 85.01 
SAUSA300s151 Teg134 0 204.13 
a SAM, S-adenosylmethionine.
b RPKM, reads per kilobase of transcript per million mapped reads.
Carroll et al.
8 ® mbio.asm.org January/February 2016 Volume 7 Issue 1 e01990-15
 o
n
 August 17, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
blot analysis of tsr25 and rsaOG (a previously identified sRNA
which showed the second highest degree of upregulation in serum,
376-fold), confirming the predicted size and upregulation of both
sRNAs in human serum (Fig. 5A). RNAIII was downregulated
13-fold in the RNA-seq data analysis, and we also confirmed this
by Northern blotting (Fig. 5B). These results corroborate previ-
ously published data (18) and provide validation for the experi-
mental techniques described herein.
The data presented above represent the first global transcrip-
tomic analysis of sRNA gene expression in the CA-MRSA strain
USA300 and demonstrate the utility of the sRNA annotation files
constructed in this study. The biological functions of most sRNAs
are unknown, making it difficult to ascertain the impact on the
bacterial cell of their differential regulation. Studying the variation
in sRNA expression in response to changing environmental con-
ditions may provide insight into which sRNAs play a role in the
adaptive nature of S. aureus. tsr25 and rsaOG, for example, are
upregulated 300-fold in human serum, suggesting a role for
these molecules under these conditions. In addition, a number of
conserved, well-studied sRNAs were among those differentially
regulated in human serum. 4.5S RNA (SAUSA300s005) and ssrS
(SAUSA300s026) demonstrated increased expression in human
serum (12-fold increase for both). The increased expression of
these RNA species may reflect physiological changes to the bacte-
rial cell in this environmental niche (see Discussion).
DISCUSSION
In 1995, the release of the first fully sequenced bacterial genome
heralded a new era of bacterial genomic research (21). Over the
past 20 years, the number of sequenced bacterial genomes has
risen exponentially, and new research strategies, techniques, and
applications have emerged to exploit the opportunities that these
resources provide. While raw genomic sequence data are valuable,
the availability of fully annotated genome sequences, outlining the
positions of known genes and genomic features, dramatically in-
creases their utility. Global expression analysis techniques such as
TABLE 3 41 sRNAs that are downregulated in human serum versus TSB
sRNA designation
sRNA gene name
or feature
TSB expression
value (RPKM)a
Serum expression
value (RPKM) Fold change
SAUSA300s277 tsr13 509.65 0.43 1,187.67
SAUSA300s113 sbrC 1,834.12 6.3 291.07
SAUSA300s266 tsr2 122.44 0.42 290.6
SAUSA300s296 tsr32 92.33 0.44 210.63
SAUSA300s171 Sau-6569 41,077.46 250.83 163.77
SAUSA300s049 RsaC 8,079.72 77.42 104.37
SAUSA300s004 Purine riboswitch 2,277.90 45.36 50.22
SAUSA300s303 tsr39 3,132.51 64.48 48.58
SAUSA300s162 Teg25as 6,668.30 191.51 34.82
SAUSA300s125 ssr47 6,272.84 256.03 24.5
SAUSA300s052 RsaF 35,374.06 1,713.79 20.64
SAUSA300s275 tsr11 398.93 20.01 19.94
SAUSA300s301 tsr37 390.39 23.36 16.72
SAUSA300s292 tsr28 513.06 31.91 16.08
SAUSA300s297 tsr33 8,987.32 592.2 15.18
SAUSA300s062 Sau-31 141.32 9.7 14.57
SAUSA300s022 RNAIII 66,968.70 5,178.15 12.93
SAUSA300s283 tsr19 162.04 13.93 11.63
SAUSA300s118 ssr16 478.47 49.19 9.73
SAUSA300s302 tsr38 251.17 27.55 9.12
SAUSA300s280 tsr16 254.42 30.88 8.24
SAUSA300s095 Teg116 1,149.05 155.21 7.4
SAUSA300s211 JKD6008sRNA073 59.06 8 7.38
SAUSA300s287 tsr23 970.48 133.71 7.26
SAUSA300s054 RsaH 4,110.36 629.99 6.52
SAUSA300s087 Teg41 481.01 74.55 6.45
SAUSA300s078 rsaOT 17,890.11 2,790.22 6.41
SAUSA300s127 ssr54 3,245.19 584.15 5.56
SAUSA300s051 RsaE 2,929.20 534.76 5.48
SAUSA300s074 rsaOI 721.93 135.52 5.33
SAUSA300s237 JKD6008sRNA258 100.89 20.87 4.83
SAUSA300s298 tsr34 200.17 41.54 4.82
SAUSA300s267 tsr3 85.01 19.21 4.43
SAUSA300s114 sbrE 424.58 102.21 4.15
SAUSA300s073 Sau-6072 265.82 64.27 4.14
SAUSA300s276 tsr12 295.29 73.2 4.03
SAUSA300s291 tsr27 135.22 34.48 3.92
SAUSA300s204 RsaX04 265.58 70.09 3.79
SAUSA300s086 Teg39 50.39 13.67 3.69
SAUSA300s141 ssr153 74.69 21.06 3.54
SAUSA300s010 T-box riboswitch 487.82 149.37 3.27
a RPKM, reads per kilobase of transcript per million mapped reads.
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microarrays and RNA-seq depend heavily on annotated genome
sequences as a reference source for genes in the bacterial cell.
These techniques have proved extremely useful; however, re-
cently, certain limitations to their application are becoming ap-
parent. A major concern in this regard is that they do not provide
expression data for genes that are not included in genome anno-
tation files. Bacterial sRNAs represent a class of genes that are
frequently absent from genome annotation files; consequently,
their expression is rarely studied on a global level. In this work, we
added annotations for 303 sRNA genes to the S. aureus USA300
genome, increasing the number of annotated genes from 2,850 to
3,153 (a 10% increase). Including sRNA gene annotations in S. au-
reus GenBank files facilitates global expression analysis of these
understudied molecules. The 303 newly added annotations un-
doubtedly do not represent an exhaustive list of the complete
S. aureus sRNA repertoire, as it is likely that subsequent studies,
using different techniques and environmental conditions, will
continue to add to this number. It is also likely that among the 303
annotations, there may be false positives as only 92 of the 303
sRNAs reported and annotated here (30%) have been confirmed
by independent experimental methods other than high-
throughput sequencing and microarray hybridization. Therefore,
while the sRNA annotated GenBank files generated herein may
not be definitive, they nonetheless represent a significant step for-
ward and pave the way for future studies that can validate the
existence, elucidate the role, and demonstrate the biological im-
pact of these molecules on S. aureus physiology and virulence.
The 303 sRNA genes annotated in this study (representing 10%
of all known genes on the S. aureus genome) were identified in
S. aureus growing under a limited number of environmental con-
ditions. How many sRNAs remain unidentified is unknown; how-
ever, on the basis of the data presented in this study and by others
(14), it seems likely that sRNA genes may account for15 to 20%
of all transcripts in the S. aureus cell. Importantly, a benefit of the
nomenclature system used in this study to annotate sRNAs (in
addition to keeping original names intact) is that it can be ex-
panded upon to accommodate new sRNAs as they are identified.
An unexpected observation arising from this study is the lack of
consistency in genome annotation across multiple strains of S. au-
reus. The examples highlighted in this study (specifically tsr12 and
Teg23) demonstrate that this phenomenon occurs even at
genomic loci with a high degree of homology (100% identical in
the case of tsr12 in strains USA300 and NCTC 8325). Genome
annotation is typically performed bioinformatically and is rarely
validated and curated (22); therefore, this variation in annotation
likely arises because different annotation pipelines have been used
to annotate different genomes. This raises the important question
of whether certain genomes have been under- and/or overanno-
tated. It is likely that examples of both situations occur; however,
on the basis of our data, it appears that the overannotation of
genomes (i.e., the inclusion of CDS annotations that are not legit-
imate mRNA transcripts) is common and could have deleterious
consequences for sRNA identification and study. sRNA tran-
scripts that map to genomic regions containing CDS annotations
will mistakenly be assumed to encode proteins. Highlighting this
point is the data presented in Fig. 3, which strongly suggest that
Teg23 is an sRNA and not a protein. Nonetheless, we acknowledge
that this type of data, by its very nature, cannot exclude the possi-
bility that such a gene/protein exists, and hence, once a CDS has
been annotated, it is difficult or impossible to conclusively prove
that it does not exist. Careful attention must be paid to the loca-
tion of transcript start/stop sites, the existence of ribosome bind-
ing sites and the predicted function of annotated genes. We ob-
served many instances of inconsistent genome annotation where a
given gene encoded a protein of unknown function with no ho-
mologues and no functional domains. This lack of homology may
indicate that while sequence analysis alone may suggest that a gene
is possible at this locus, it is not certain to exist. The results pre-
sented herein are a timely reminder that, although genome anno-
tation files are valuable resources that are increasingly relied upon
by next-generation DNA sequencing technology, these annota-
tions should be treated with a reasonable degree of caution and
not seen as an infallible reference. Confirmation of the existence of
a gene/transcript/protein by traditional biochemical methods
(such as 5= and 3= rapid amplification of cDNA ends [RACE],
primer extension, and in vivo translation) remains essential.
Including sRNA annotations in GenBank files allowed us to
perform global sRNA expression analysis by RNA-seq for the first
time in the CA-MRSA isolate USA300. The data generated dem-
FIG 5 Northern blot analysis of serum-regulated sRNAs in strain USA300.
(A) Analysis of sRNAs demonstrating upregulation in human serum. RNA-seq
read alignment data and Northern blot analysis are shown for SAUSA300s289
(tsr25) and SAUSA300s046 (rsaOG) during growth in TSB (T) or human se-
rum (S). (B) Analysis of RNAIII expression in human serum and TSB. RNA-
seq read alignment data are shown for the entire agr locus. Northern blot
analysis was performed using an oligonucleotide probe specific for the RNAIII
transcript. Annotations for CDS genes are shown by black arrows, annotations
for sRNAs are shown by red arrows, and depth of read coverage on the genome
is shown by the blue histograms.
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onstrated that 83 sRNAs are differentially expressed in TSB versus
human serum (Tables 2 and 3). This represents 27% of the known
sRNAs in strain USA300. It is not easy to interpret how their
differential regulation affects the bacterial cell (because the bio-
logical functions of most of them are unknown); however, certain
inferences can be made. The newly identified tsr25 sRNA demon-
strated a 582-fold increase in expression in human serum. It is
tempting to speculate that increased expression of tsr25 in serum
suggests that it plays an important role during S. aureus blood-
stream infections. A small number of conserved, well-studied
sRNAs were also among the differentially regulated sRNAs in se-
rum. 4.5S RNA, a component of the signal recognition particle,
was upregulated 12-fold in human serum, perhaps reflecting al-
tered protein secretion and/or protein composition in the cell
membrane in this environment. Another important cellular RNA
that has been well explored is 6S RNA (ssrS), which we demon-
strate also has a 12-fold increase in expression during growth in
serum. In Escherichia coli, 6S RNA binds to the housekeeping
sigma factor 70 and inhibits transcription from 70-dependent
promoters. It is thought that this diverts RNA polymerase to al-
ternative sigma factors (such as the stress response sigma factor),
resulting in increased expression of adaptive and stress-
circumventing genes (23). The upregulation of ssrS in human se-
rum suggests that a similar situation occurs in S. aureus, whereby
A-dependent genes are downregulated and B-dependent genes
are upregulated by the action of 6S RNA.
Examining the global transcriptome can provide valuable in-
sights into bacterial physiology and adaptation to environmental
conditions. In the past, global transcriptomic analysis has focused
on protein-coding genes, but here, we conduct global transcrip-
tomic analysis and include newly annotated sRNA genes. Like
protein-coding genes, sRNA genes display differential regulation
that allow bacteria to adapt to environmental changes. The anno-
tation files presented herein, which facilitate this kind of global
analysis will prove to be a valuable resource for the future study of
sRNAs in S. aureus and will more generally broaden our under-
standing of regulatory circuits.
MATERIALS AND METHODS
Strains, plasmids, and primers. Bacterial strains, plasmids, and primers
used in this study are listed in Table 4. S. aureus and E. coli were grown
routinely at 37°C with shaking in tryptic soy broth (TSB) and lysogeny
broth (LB), respectively. Pooled human serum from anonymous donors,
purchased from MP Biomedicals, was used for growth of S. aureus strain
USA300. When necessary, antibiotics were added at the following concen-
trations: ampicillin, 100 g ml1; chloramphenicol, 5 g ml1.
RNA-seq. Samples for transcriptome sequencing (RNA-seq) were
prepared as follows for S. aureus USA300 and SH1000. Overnight cultures
were diluted 1:100 in 100 ml of fresh TSB and grown at 37°C with shaking
for 3 h. Exponentially growing cultures were then diluted and synchro-
nized by inoculating fresh 100-ml flasks of TSB at an optical density at 600
nm (OD600) of 0.05, or in the case of strain USA300 growing in serum,
10 ml of human serum in a 50-ml tube. Synchronized cultures were grown
for 3 h at 37°C with shaking, at which time bacteria were pelleted by
centrifugation and stored at 80°C prior to RNA isolation. S. aureus
UAMS-1 (a USA200 strain and close relative of MRSA252) overnight
cultures were diluted to an optical density of 0.05 in 40 ml of TSB con-
taining no dextrose (1:12.5 volume-to-flask volume ratio). Cultures were
grown at 37°C with shaking for 4 h, before cells were harvested and stored
as described above. For each RNA-seq sample, three replicate cultures
were grown, and three biological replicate RNA isolations were performed
(using the procedure outlined in reference 24). For each sample, equimo-
lar amounts of the three biological replicate RNA preparations were
mixed prior to rRNA reduction. The subsequent RNA-seq analysis there-
fore represents the average of three biological replicates. RNA-seq and
data analysis were carried out using the protocol previously published by
our research group (24).
Bioinformatics, sRNA identification, and genome annotation. The
CLC Genomics Workbench software platform (Qiagen) was used for all
RNA-seq data analysis and for construction of new GenBank files. Anno-
tated genome files for S. aureus N315, USA300, MRSA252, and NCTC
8325 (GenBank accession numbers NC_002745, CP000255, NC_002952,
and NC_007795, respectively) were downloaded from NCBI. The loca-
tion, sequence, and orientation of previously described sRNAs on the
N315 genome were calculated based on the information provided in pub-
lished manuscripts and supplemental information files of the relevant
studies (1–12). Using the CLC Genomics Workbench built-in BLAST
feature, the corresponding positions for sRNAs were identified in the
genomes of strains USA300, MRSA252, and NCTC 8325. The location
and orientation of each sRNA was then annotated.
Northern blots. Northern blots to identify the size and abundance of
sRNAs were performed by the method of Caswell et al. (25). Briefly, 10g
of total RNA isolated from a 3 h USA300 culture in TSB were loaded on a
10% polyacrylamide gel (7 M urea, 1 Tris-borate-EDTA [TBE]) and
separated by gel electrophoresis. The samples were then transferred via
electroblotting to an Amersham Hybond N membrane (GE Health-
care). The membrane was exposed to UV light to cross-link samples to the
membrane. Subsequently, membranes were prehybridized (1 h, 45°C) in
ULTRAhyb-Oligo buffer (Ambion) and then incubated (16 h, 45°C) with
sRNA-specific oligonucleotide probes end labeled with [-32P]ATP and
T4 polynucleotide kinase (Thermo Scientific). After incubation, mem-
branes were washed with 2, 1, and 0.5 SSC buffer (1 SSC is 300
mM sodium chloride and 30 mM sodium citrate) at 45°C for 30 min each
to remove unspecific bound probes. Finally, X-ray film was exposed to
membranes for sRNA detection.
Cloning of histidine-tagged Teg23P. The genomic region containing
Teg23P (including its native promoter) was amplified using USA300
genomic DNA and primers OL3222 and OL3223. The reverse primer
OL3223, in addition to the gene-specific region, carries a sequence that
encodes a hexahistidine (His6) tag, which allows the detection of a possi-
ble encoded protein via Western blotting. The amplified 761-bp product
was cloned into shuttle vector pMK4, and the plasmid was transformed
into chemically competent E. coli DH5. The resulting colonies were
screened for correct constructs employing a colony PCR approach using
identical primers to those used for the amplification of the initial frag-
ment. After identification of positive clones, the plasmid was verified via
Sanger sequencing with the plasmid-specific standard primers M13Fw
(Fw stands for forward) and M13Rv (Rv stands for reverse) (Eurofins
MWG Operon). This construct was then transformed into S. aureus
RN4220 and confirmed via PCR. Finally, the plasmid was transduced into
S. aureus USA300 using a11 phage lysate, and after final confirmation of
the construct using PCR, the strain was utilized for subsequent analysis.
qRT-PCR. Quantitative reverse transcriptase PCR (qRT-PCR) was
conducted as described by our research group previously (26), employing
the teg23-specific primers OL3281, OL3282, OL3232, and OL3282 and
RNA isolated from S. aureus USA300 cultures grown in TSB as described
above for RNA-seq experiments. As a reference, 16S rRNA was amplified
using primers OL1184 and OL1185 (27). All experiments were performed
in triplicate.
Western blots. The evaluation of Teg23 protein abundance was per-
formed by Western immunoblotting as described previously (28).
USA300 cells harboring the His6-tagged version of Teg23P were grown for
3 h in TSB, before they were pelleted and their cytoplasmic proteins were
isolated. Following SDS-polyacrylamide gel electrophoresis and transfer
of the separated proteins to a polyvinylidene difluoride (PVDF) mem-
brane, detection was performed using anti-His monoclonal mouse anti-
body (Covance) and horseradish peroxidase (HRP)-conjugated anti-
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mouse secondary antibody. Subsequently, HRP activity was detected and
visualized on X-ray film. Histidine-tagged RpoE, a protein previously de-
scribed by our group, was included as a control for successful protein
transfer and immunodetection (16).
Accession numbers. The GenBank files generated have been depos-
ited in figshare (https://dx.doi.org/10.6084/m9.figshare.2061132.v1). The
files are provided in .gkb format and can be viewed using a variety of
genome browser software (examples of freely available genome browsers
include Artemis, Genome Compiler, and CLC Sequence Viewer). The
RNA-seq data files have been deposited in GEO under accession number
GSE74936. Newly identified sRNAs (i.e., the tsr sRNAs) have been depos-
ited in GenBank under accession numbers KU639719-KU639757 for
SAUSA300s265-SAUSA300s303, KU639758-KU639789 for SAOUHSCs255-
SAOUHSCs286, and KU639790-KU639818 for SARs249-SARs277.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at http://mbio.asm.org/
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